Quadro-Iliac Plane Block for Analgesia After Lumbar Microdiscectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorKanuni Sultan Suleyman Training and Research Hospital

About this trial

This study will evaluate whether ultrasound-guided quadro-iliac plane block provides better postoperative pain control than local infiltration analgesia in patients undergoing single-level lumbar microdiscectomy.

Adult patients scheduled for elective single-level lumbar microdiscectomy will be randomly assigned to receive either bilateral quadro-iliac plane block plus patient-controlled analgesia or local infiltration analgesia plus patient-controlled analgesia. The main outcome of the study will be total fentanyl consumption during the first 24 hours after surgery. Pain scores, need for rescue analgesia, opioid-related side effects, patient satisfaction, and recovery quality will also be evaluated.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 to 75 years

American Society of Anesthesiologists physical status I to III

Scheduled for elective single-level lumbar microdiscectomy, such as L4-L5 or L5-S1 disc herniation

Planned surgery under general anesthesia

Disqualifiers

Allergy or hypersensitivity to local anesthetics

Coagulopathy or active anticoagulant use

Infection, scar tissue, or skin lesion at the injection site

Pregnancy or breastfeeding

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ultrasound-Guided Quadro-Iliac Plane Block

    Procedure/Surgery

    Bilateral ultrasound-guided quadro-iliac plane block will be performed before emergence from general anesthesia in the prone position. After visualization of the quadratus lumborum muscle and iliac crest at the L3 level, 30 mL of 0.167% bupivacaine will be injected into the interfascial plane on each side. All participants will receive postoperative fentanyl-based patient-controlled analgesia.

  • Local Infiltration Analgesia (LIA)

    Procedure/Surgery

    Local infiltration analgesia will be performed by the surgeon before the end of surgery. A total dose of 50 mg of 0.25% bupivacaine will be infiltrated into the subcutaneous tissue. All participants will receive postoperative fentanyl-based patient-controlled analgesia.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Quadro-Iliac Plane Block GroupActive comparator 1 intervention
Group B: Local Infiltration Analgesia GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Total Fentanyl Consumption During the First 24 Hours After Surgery

Total postoperative fentanyl consumption administered via patient-controlled analgesia will be recorded during the first 24 hours after surgery.

Time frame
Postoperative 0-24 hours

Secondary outcomes

1

Postoperative Pain Scores at Rest and During Movement

Pain intensity will be assessed using the Numerical Rating Scale at rest and during movement. The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.

Time frame
Postoperative 0, 1, 6, 12, and 24 hours
2

Number of Patients Require Rescue Analgesic

The need for rescue analgesia with intravenous tenoxicam will be recorded during the postoperative follow-up period.

Time frame
Postoperative 0-24 hours
3

Opioid-Related Adverse Effects

Opioid-related adverse effects, including nausea, vomiting, pruritus, and respiratory depression, will be recorded.

Time frame
Postoperative 0-24 hours
4

Quality of Recovery Score

Patient-reported recovery quality will be assessed using the Quality of Recovery-15 questionnaire (0-150). Higher value means better Quality of Recovery.

Time frame
Postoperative 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.